Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	2% sodium chondroitin sulfate	Chondroitin sulfate	1件: D00080 💬	-	-	1件: 226 💬
2	5% lidocaine/5 mg/ml 0.02% estradiol compound cream	Estradiol	11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬	7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway	1件: 226 💬
3	Adalimumab	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
4	Agn 203818	-	-	-	-	1件: 226 💬
5	Alkalinized lidocaine-heparin	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
6	Amitriptyline	Amitriptyline	2件: D00809, D07448 💬	2件: SLC6A2, SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle	4件: 78, 97, 226, 299 💬
7	Aqx-1125	AQX-1125	-	-	-	1件: 226 💬
8	Aqx-1125 100 mg	AQX-1125	-	-	-	1件: 226 💬
9	Aqx-1125 200 mg	AQX-1125	-	-	-	1件: 226 💬
10	Asp3652	-	-	-	-	1件: 226 💬
11	Asp6294	-	-	-	-	1件: 226 💬
12	Bladder instillation with heparin/ lidocaine	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
13	Bladder instillation with triamcinolone acetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 226 💬
14	Bladder instillation without triamcinolone acetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 226 💬
15	Bladder instillations	-	-	-	-	1件: 226 💬
16	Botox	-	-	-	-	6件:  2 ,  6 , 13, 51, 149, 226 💬
17	Botox 200u in normal saline	-	-	-	-	1件: 226 💬
18	Botulinum toxin a	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	4件: 13, 51, 149, 226 💬
19	Buckwheat	Buckwheat	-	-	-	1件: 226 💬
20	Bupivacaine	Bupivacaine	2件: D01450, D07552 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	8件: 46, 51, 53, 70, 96, 168, 226, 298 💬
21	Cannabidiol	Cannabidiol	1件: D10915 💬	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	17件:  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
22	Cannabidiol vaginal suppository	Cannabidiol	1件: D10915 💬	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	1件: 226 💬
23	Capsaicin	Capsaicin	1件: D00250 💬	1件: TRPV1 💬	2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	5件:  2 ,  6 , 19, 86, 226 💬
24	Certolizumab pegol	Certolizumab pegol	1件: D03441 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	6件: 37, 46, 96, 97, 226, 271 💬
25	Chondroitin sulfate	Chondroitin sulfate	1件: D00080 💬	-	-	2件: 96, 226 💬
26	Ciclosporin	Cyclosporine	1件: D00184 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬
27	Ciklosporin	-	-	-	-	1件: 226 💬
28	Combination product: hyperbaric oxygen therapy-	Oxygen	1件: D00003 💬	-	-	1件: 226 💬
29	Cyclosporine	Cyclosporine	1件: D00184 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
30	Device: interferential current	-	-	-	-	1件: 226 💬
31	Device: intermittent exposure to oxygen via oro-nasal mask	Oxygen	1件: D00003 💬	-	-	1件: 226 💬
32	Dexmedetomidine	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
33	Dimethyl sulfoxide	Dimethyl sulfoxide	1件: D01043 💬	-	-	1件: 226 💬
34	Dmso	Dimethyl sulfoxide	1件: D01043 💬	-	-	1件: 226 💬
35	Dmso cocktail	Dimethyl sulfoxide	1件: D01043 💬	-	-	1件: 226 💬
36	Erb-041	-	-	-	-	3件: 46, 96, 226 💬
37	Estradiol	Estradiol	8件: D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	5件: 13, 46, 49, 226, 299 💬
38	Fospropofol	Fospropofol	1件: D04257 💬	-	-	1件: 226 💬
39	Fospropofol (lusedra®) 10	Fospropofol	1件: D04257 💬	-	-	1件: 226 💬
40	Fospropofol (lusedra®) 12	Fospropofol	1件: D04257 💬	-	-	1件: 226 💬
41	Fospropofol (lusedra®) 6.5	Fospropofol	1件: D04257 💬	-	-	1件: 226 💬
42	Fremanezumab	Fremanezumab	1件: D11055 💬	1件: CALCA 💬	2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction	2件: 124, 226 💬
43	Gefapixant	Gefapixant	1件: D11349 💬	1件: P2RX3 💬	3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction	2件: 85, 226 💬
44	Glycine	Glycine	1件: D00011 💬	-	-	5件: 35, 60, 86, 226, 299 💬
45	Gralise	-	-	-	-	2件: 97, 226 💬
46	Heparin	Heparin	1件: D07510 💬	1件: SERPINC1 💬	1件: Complement and coagulation cascades	11件: 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 💬
47	Heparin & alkalinized lidocaine bladder instillation	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
48	Hyaluronic acid	Hyaluronic acid	1件: D08043 💬	-	-	5件: 46, 53, 70, 226, 231 💬
49	Hyaluronic acid and chondroitin sulfate	Chondroitin sulfate	2件: D00080, D08043 💬	-	-	1件: 226 💬
50	Hyaluronic acid/chondroitin sulfate	Chondroitin sulfate	2件: D00080, D08043 💬	-	-	1件: 226 💬
51	Hydrogen	Hydrogen	-	-	-	7件:  5 ,  6 , 13, 17, 83, 97, 226 💬
52	Ic cocktail	-	-	-	-	1件: 226 💬
53	Intravesical onabotulinumtoxina injection	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 226 💬
54	Ipd® (japanese tradename)	-	-	-	-	1件: 226 💬
55	Ipd® (suplatast tosilate)	-	-	-	-	1件: 226 💬
56	Jnj-42160443	-	-	-	-	1件: 226 💬
57	Ketorolac	Ketorolac	2件: D00813, D08104 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	2件: 70, 226 💬
58	Ketorolac tromethamine	Ketorolac	3件: D00396, D00813, D08104 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 226 💬
59	Krp-116d	-	-	-	-	1件: 226 💬
60	Lidocaine	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
61	Lidocaine releasing intravesical system - liris®	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 226 💬
62	Liposome encapsulated bont-a	-	-	-	-	1件: 226 💬
63	Liposomes	-	-	-	-	1件: 226 💬
64	Liris 400 mg	-	-	-	-	1件: 226 💬
65	Liris low dose and liris high dose	-	-	-	-	1件: 226 💬
66	Liris®	-	-	-	-	1件: 226 💬
67	Liris® 400 mg	-	-	-	-	1件: 226 💬
68	Low-dose naltrexone	Naltrexone	2件: D02095, D05113 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
69	Lp-08 20mg	-	-	-	-	1件: 226 💬
70	Lp-08 80mg	-	-	-	-	1件: 226 💬
71	Metoprolol	Metoprolol	3件: D00601, D02358, D05011 💬	1件: ADRB1 💬	10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	6件: 17, 57, 58, 113, 193, 226 💬
72	Metoprolol tartrate oral tablet	Metoprolol	3件: D00601, D02358, D05011 💬	1件: ADRB1 💬	10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
73	Mirabegron	Mirabegron	1件: D09535 💬	1件: ADRB3 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway	3件:  6 , 13, 226 💬
74	Mmf	-	-	-	-	13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬
75	Mn-001	-	-	-	-	1件: 226 💬
76	Mn-001 bid	-	-	-	-	1件: 226 💬
77	Mr-mc-01	-	-	-	-	1件: 226 💬
78	Mycofenolate mofetil (mmf)	-	-	-	-	1件: 226 💬
79	Mycophenolate	Mycophenolic acid	1件: D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
80	Mycophenolate mofetil	Mycophenolate mofetil	4件: D00752, D05094, D05095, D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	32件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
81	Naloxone	Naloxone	2件: D01340, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	2件:  6 , 226 💬
82	Naloxone hydrochloride	Naloxone	2件: D01340, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
83	Naltrexone	Naltrexone	2件: D02095, D05113 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	12件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
84	Normal saline	-	-	-	-	16件:  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬
85	Normal saline instillation	-	-	-	-	1件: 226 💬
86	Nortriptyline	Nortriptyline	2件: D00816, D08288 💬	2件: SLC6A2, SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle	2件:  6 , 226 💬
87	Omalizumab	Omalizumab	1件: D05251 💬	1件: FCER1A 💬	4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway	7件: 46, 53, 65, 98, 162, 226, 299 💬
88	Onabotulinum toxin a	-	-	-	-	1件: 226 💬
89	Onabotulinumtoxin a	-	-	-	-	2件: 51, 226 💬
90	Onabotulinumtoxina	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	3件:  6 , 13, 226 💬
91	Other: hyperbaric oxygen therapy	Oxygen	1件: D00003 💬	-	-	2件: 97, 226 💬
92	Other: inactive drug	-	-	-	-	1件: 226 💬
93	Other: normal saline	-	-	-	-	4件: 13, 222, 226, 280 💬
94	Other: saline as a nasal spray	-	-	-	-	1件: 226 💬
95	Oxn 10/5 mg pr	-	-	-	-	1件: 226 💬
96	Oxn 20/10 mg pr	-	-	-	-	1件: 226 💬
97	Oxn 5/2.5 mg pr	-	-	-	-	1件: 226 💬
98	Oxycodone	Oxycodone	3件: D03783, D05312, D05462 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	7件:  6 , 13, 46, 70, 226, 231, 298 💬
99	Oxycodone hydrochloride	Oxycodone	3件: D03783, D05312, D05462 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	4件:  6 , 70, 226, 298 💬
100	Oxycodone naloxone prolonged release tablets	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
101	Oxycodone/naloxone prolonged release t	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
102	Oxycodone/naloxone prolonged release tablets 10/5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
103	Oxycodone/naloxone prolonged release tablets 20/10 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
104	Oxycodone/naloxone prolonged release tablets 5/2.5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
105	Oxygen	Oxygen	1件: D00003 💬	-	-	18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
106	Oxytocin	Oxytocin	1件: D00089 💬	1件: OXTR 💬	4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway	5件:  6 , 127, 193, 206, 226 💬
107	Pd 0299685	-	-	-	-	1件: 226 💬
108	Pd 0299685 at 15mg bid	-	-	-	-	1件: 226 💬
109	Pd 0299685 at 30mg bid	-	-	-	-	1件: 226 💬
110	Pd-0299685	PD-0299685	-	-	-	1件: 226 💬
111	Pentosan polysulfate	Pentosan polysulfate	1件: D05428 💬	-	-	3件: 19, 26, 226 💬
112	Pentosan polysulfate sodium 100 mg	Pentosan polysulfate	1件: D05428 💬	-	-	1件: 226 💬
113	Pf-04383119	-	-	-	-	1件: 226 💬
114	Placebo	-	-	-	-	26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
115	Platelet enriched plasma	-	-	-	-	1件: 226 💬
116	Platelet-rich plasma	-	-	-	-	1件: 226 💬
117	Procedure: injections on posterior bladder wall excluding the trigone	-	-	-	-	1件: 226 💬
118	Procedure: injections upper aspect of trigone of urinary bladder	-	-	-	-	1件: 226 💬
119	Procedure: pelvic floor physical therapy	-	-	-	-	1件: 226 💬
120	Procedure: sham cystoscopy procedure	-	-	-	-	1件: 226 💬
121	Procedure: urodynamic study	-	-	-	-	1件: 226 💬
122	Prograf	-	-	-	-	3件: 60, 222, 226 💬
123	Propiverine	Propiverine	1件: D08441 💬	9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	42件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
124	Propiverine hydrochloride	Propiverine	1件: D08441 💬	9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	42件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
125	Rimso 50	-	-	-	-	1件: 226 💬
126	Rn624, ri624	-	-	-	-	1件: 226 💬
127	Sandimmun	-	-	-	-	2件: 97, 226 💬
128	Sandimmun neoral	-	-	-	-	3件: 60, 97, 226 💬
129	Si-722	-	-	-	-	1件: 226 💬
130	Sildenafil	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
131	Sulfate	Sulfate ion	-	-	-	25件:  2 ,  6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
132	Suplatast tosilate	-	-	-	-	1件: 226 💬
133	Tacrolimus	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	32件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
134	Tanezumab	Tanezumab	1件: D09387 💬	1件: NGF 💬	9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway	2件: 226, 298 💬
135	Targinact 10 mg/5 mg prolonged-release tablets	-	-	-	-	2件:  6 , 226 💬
136	Targinact 20mg/10 mg prolonged-release tablets	-	-	-	-	1件: 226 💬
137	Targinact 5mg/2.5 mg prolonged-release tablets	-	-	-	-	1件: 226 💬
138	Tramadol	Tramadol	2件: D01355, D08623 💬	1件: OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	5件: 46, 70, 78, 226, 271 💬
139	Triamcinolone	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
140	Tromethamine	Tromethamine	1件: D00396 💬	-	-	1件: 226 💬
141	Tti-1612	-	-	-	-	1件: 226 💬
142	Urg101	-	-	-	-	1件: 226 💬
143	Water	Water	1件: D00001 💬	-	-	22件:  2 ,  5 ,  6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬
144	Ym672	-	-	-	-	1件: 226 💬
145	Ym672 (ipd®)	-	-	-	-	1件: 226 💬

先頭へ